AHCO:NSD-AdaptHealth Corp (USD)

COMMON STOCK | Medical Devices | NSD

Last Closing Price

USD 17.80

Change

0.00 (0.00)%

Market Cap

USD 1.31B

Volume

0.17M

Average Target Price

USD 15.29 (-14.13%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, supplies, and related services in the United States. The company focuses primarily on providing sleep therapy equipment, supplies, and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It services beneficiaries of Medicare, Medicaid, and commercial payors. The company is based in Plymouth Meeting, Pennsylvania.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-05 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALGN Align Technology, Inc

N/A

USD12.14B 32.01 N/A
PODD Insulet Corporation

N/A

USD10.37B 872.00 N/A
ABMD Abiomed, Inc

N/A

USD6.29B 27.11 22.11
BRKR Bruker Corporation

N/A

USD5.19B 29.26 N/A
TNDM Tandem Diabetes Care, Inc

N/A

USD3.66B N/A N/A
IART Integra LifeSciences Holdings ..

N/A

USD3.50B 77.02 N/A
WMGI Wright Medical Group N.V

N/A

USD3.39B N/A N/A
LVGO Livongo Health, Inc

N/A

USD2.79B N/A N/A
NUVA NuVasive, Inc

N/A

USD2.27B 41.19 N/A
LIVN LivaNova PLC

N/A

USD2.05B 77.40 N/A

ETFs Containing AHCO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Devices)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 62.11% 97% A+ 97% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 62.11% 97% A+ 97% A+
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 1.31B 86% B 79% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Devices)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 21.60 17% F 10% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -35.05% 53% F 27% F
Return on Invested Capital 14.67% 86% B 86% B
Return on Assets 6.42% 89% B+ 88% B+
Debt to Equity Ratio -2,763.88% 100% A+ 100% A+
Technical Ratios  
Short Ratio 6.85 17% F 18% F
Short Percent 2.77% 73% C 57% F
Beta N/A N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector